Cargando…
Inhibitor of DNA Binding 2 (ID2) Regulates the Expression of Developmental Genes and Tumorigenesis in Ewing Sarcoma
Sarcomas are difficult to treat and the therapy, even when effective, is associated with long-term and life-threatening side effects. In addition, the treatment regimens for many sarcomas, including Ewing sarcoma, rhabdomyosarcoma, and osteosarcoma, are relatively unchanged over the past two decades...
Autores principales: | Koppenhafer, Stacia L., Goss, Kelli L., Voigt, Ellen, Croushore, Emma, Terry, William W., Ostergaard, Jason, Gordon, Peter M., Gordon, David J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107507/ https://www.ncbi.nlm.nih.gov/pubmed/35422476 http://dx.doi.org/10.1038/s41388-022-02310-0 |
Ejemplares similares
-
Activator Protein-1 (AP-1) Signaling Inhibits the Growth of Ewing Sarcoma Cells in Response to DNA Replication Stress
por: Croushore, Emma E., et al.
Publicado: (2023) -
Eltrombopag inhibits the proliferation of Ewing sarcoma cells via iron chelation and impaired DNA replication
por: Waters, Torin, et al.
Publicado: (2020) -
Inhibition of CHK1 sensitizes Ewing sarcoma cells to the ribonucleotide reductase inhibitor gemcitabine
por: Goss, Kelli L, et al.
Publicado: (2017) -
The translational repressor 4E-BP1regulates RRM2 levels and functions as a tumor suppressor in Ewing Sarcoma Tumors
por: Goss, Kelli L., et al.
Publicado: (2020) -
Gene expression signature based screening identifies ribonucleotide reductase as a candidate therapeutic target in Ewing sarcoma
por: Goss, Kelli L., et al.
Publicado: (2016)